Hormonal treatments for premenstrual syndrome

Drugs of Today

Volumn 34, Issue 7, 1998, Pages 603-610

  Kouri, Elena M ^a   Halbreich, Uriel ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGESTAGEN; CHORIONIC GONADOTROPIN; DANAZOL; DYDROGESTERONE; ESTRADIOL; ESTROGEN; GONADORELIN AGONIST; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE; MIFEPRISTONE; ORAL CONTRACEPTIVE AGENT; PLACEBO; PROGESTERONE;

AMENORRHEA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HORMONAL THERAPY; HOT FLUSH; HUMAN; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; OVULATION; PREMENSTRUAL SYNDROME; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSDERMAL DRUG ADMINISTRATION; VAGINA BLEEDING;

EID: 0031878016     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.1998.34.7.485258     Document Type: Review

References (73)

1. Magos, A.L., Studd, J.W.W. Assessment of menstrual cycle symptoms by trend analysis. Am J Obstet Gynecol 1986, 155: 271-7.
2. Johnson, S. The epidemiology and social impact of premenstrual symptoms. Clin Obstet Gynecol 1987, 30: 369-84.
3. Ramcharan, S., Love, E., Fick, G. et al. The epidemiology of premenstrual symptoms in a population-based sample of 2650 urban women: Attributable risk and risk factors. J Clin Epidemiol 1992, 45: 377-92.
4. Rivera-Tovar, A.D., Frank. E. Late luteal phase dysphoric disorder in young women. Am J Psychiatry 1990, 147: 1634-6.
5. Studd, J.W.W. Premenstrual tension syndrome. Br Med J 1979, 1: 410-2.
6. Casson, P., Hahn, P.M., van Vugt, D.A., Reid, R.L. Lasting response to ovariectomy in severe intractable premenstrual syndrome. Am J Obstet Gynecol 1990, 162: 99-105.
7. Casper, R.F., Hearn, M.T. The effect of hysterectomy and bilateral ooporectomy in women with severe premenstrual syndrome. Am J Obstet Gynecol 1990, 162: 105-9.
8. Backstrom, C.T., Boyle, H., Baird, D.T. Persistence of symptoms of premenstrual tension in hysterectomized women. Br J Obstet Gynaecol 1981, 88: 530-5.
9. Backstrom, T., Sander, D., Laesl, R. et al. Mood, sexuality, hormones and the menstrual cycle II: Hormone levels and their relationship to premenstrual syndrome. Psychosom Med 1983, 45: 503-11.
10. Hammarback, S., Ekholm, U.B., Backstrom, T. Spontaneous anovulation causing disappearance of cyclic symptoms in women with the premenstrual syndrome. Acta Obstet Gynecol Scand 1991, 125: 132-7.
11. Hammarback, S., Backstrom, C.T., Holst, J., Van Schoultz, B., Lyrenas, S. Cyclical mood changes as in the premenstrual tension syndrome during sequential oestrogen-progestogen postmenopausal replacement therapy. Acta Obstet Gynecol Scand 1985, 64: 393.
12. Magos, A.L., Brincat, M., Studd, J.W.W. Treatment of the premenstrual syndrome by subcutaneous oestradiol implants and cyclical oral norethisterone: Placebo controlled study. Br Med J 1986, 292: 1629.
13. Watson, N.R., Studd, J.W.W. The use of estrogen in the treatment of premenstrual syndrome. In: Modem Management of Premenstrual Syndrome. Smith, S., Schiff, I. (Eds.). W.W. Norton & Co.: New York 1993, 137-51.
14. Studd, J.W.W., Smith, R.N.J. Oestradiol and testosterone implants. Baillieres Clin Endocrinol Metab 1993, 7: 203-23.
15. Watson, N.R., Studd, J.W.W., Paddle, A.F., Savvas, M. Suppression of ovulation by transdermal oestradiol patches. Br Med J 1988, 297: 900-1.
16. Watson, N.R., Studd, J.W.W., Savvas, M., Garnett, T., Baber, R.J. Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone. Lancet 1989, ii: 730-2.
17. Smith, R.N.J., Studd, J.W.W., Zamblera, D., Holland, E.F.N. A randomized comparison over 8 months of 100 g and 200 twice weekly doses of transdermal oestradiol in the treatment of severe premenstrual syndrome. Br J Obstet Gynecol 1995, 102: 475-84.
18. Halbreich, U. Premenstrual syndromes. In: Psychiatric Issues in Women. Halbreich, U. (Ed.). Bailliere Tinda1II: London 1996, 667-700.
19. Smith, R.N.J., Studd, J.W.W. Oestrogen and depression in women. In: Treatment of the Postmenopausal Woman. Lobo, R.A. (Ed.). Raven Press: New York 1994, 129-36.
20. Montgomery, J.C., Appleby, L., Brincat, M. et al. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet 1987, i: 297-9.
21. Ditkoff, E.G., Crary, W.G., Cristo, M., Lobo, R.A. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 1991, 78: 991-5.
22. Klaiber, E.L., Broverman, D.M., Vogel, W., Kobayashi, Y. Estrogen replacement therapy for severe persistent depression in women. Arch Gen Psychiatry 1979, 36: 550-4.
23. Halbreich, U., Endicott, J., Goldstein, S. Premenstrual changes and changes in gonadal hormones. Acta Psychiatr Scand 1986, 74: 576.
24. Rubinow, D.R., Hoban, M.C., Graver, G.N. et al. Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorders and in control subjects. Am J Obstet Gynecol 1988, 158: 5-11.
25. Dalton, K. (Ed.). The Premenstrual Syndrome and Progesterone Therapy. William Heinemann Medical Books: London 1984.
26. Morris, R.V. Progesterone for premenstrual tension. J Reprod Med 1983, 28: 509-16.
27. Dennerstein, L., Spencer-Gardner, C., Gotts, G. Progesterone and the premenstrual syndrome. Br Med J 1985, 290: 1017.
28. Magill, P.J. Investigation of the efficacy of progesterone pessaries in the relief of symptoms of premenstrual syndrome. Progesterone Study Group. Br J Gen Pract 1995, 45: 589-93.
29. Baker, E.R., Best, R.G., Mangredi, R.L., Demers, L.M., Wolf, G.G. Efficacy of progesterone vaginal suppositories in alleviation of nervous symptoms in patients with premenstrual syndrome. J Assist Reprod Genet 1995, 12: 205-9.
30. Freeman, E., Rickels, K., Sondheimer, S.J., Polansky, M. Ineffectiveness of progesterone suppository treatment for premenstrual syndrome. JAMA 1990, 264: 349.
31. Freeman, E., Rickels, K., Sondheimer, S.J., Polansky, M. A double-blind trial of progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. JAMA 1995, 274: 51-7.
32. Sampson, G.A. Premenstrual syndrome: A double-blind controlled trial of progesterone and placebo. Br J Psychiatr 1979, 135: 209-15.
33. Smith, S.L., Cleghom, J.M., Streiner, D.L., Younglai, E.V. A study of estrogens and progesterone in premenstrual depression: The family. P roc 4th Int Cong Psychosom Obstet Gynaecol (Tel Aviv) 1974, 538-42.
34. Andersch, B., Hahn, L. Progesterone treatment of premenstrual tension - A double-blind study. J Psychosom Res 1985, 29: 489-93.
35. Vanselow, W., Dennerstein, L., Greenwood, K.M., de Lignieres, B. Effect of progesterone and its 5α and 5β metabolites on symptoms of premenstrual syndrome according to route of administration. J Psychosom Obstet Gynaecol 1996, 17: 29-38.
36. Maddocks, S., Hahn, P., Moller, F., Reid, R. A double-blind placebo-controlled trial of progesterone vaginal suppositories in the treatment of premenstrual syndrome. Am J Obstet Gynecol 1986, 154: 573-81.
37. Schmidt, P.J., Nieman, L.K., Grover, G.N., Muller, K.L., Merriam, G.R., Rubinow, D.R. Lack of effect of induced menses on symptoms in women with premenstrual syndrome. New Engl J Med 1991, 324; 1174-9.
38. Chan, A.F., Mortola. J.F., Wood. S.H., Yen, S.S.C. Persistence of premenstrual syndrome during low-dose administration of the progesterone antagonist RU 486. Obstet Gynecol 1994, 84: 1001-5.
39. Barbieri, R.L., Ryan, K. Danazol: Endocrine pharmacology and therapeutic applications. Am J Obstet Gynecol 1981, 141: 453.
40. Andrews, M.C., Wentz, A.C. The effects of Danazol on gonadotropins and steroid blood levels in normal and anovulatory women. Am J Obstet Gynecol 1975; 121: 817.
41. Franchimont, P., Cramilion, C.L. The effect of Danazol on anterior pituitary function. Fertil Steril 1977, 28: 814.
42. Guillebaud, R.B., Fraser, I.S., Thornburn, G.D., Jenkin, G. Endocrine effects of Danazol in menstruating women. J Int Med Res 1977, 5: 57.
43. Rannevik, G., Thorell, J.I. The influence of Danazol on pituitary function and on the ovarian follicular hormone secretion in premenopausal women. Acta Obstet Gynecol Scand 1984; 123: 89.
44. Barbieri, R.L., Lee, H., Ryan, K.J. Danazol binding to rat androgen, glucocorticoid, progesterone and estrogen receptors, correlation with biologic activity. Fertil Steril 1979, 31: 182.
45. American Hospital Formulary Service. Danazol. AHFS Drug Information. Taylor Printing Co.: Hyattsville, MD 1987, 1616.
46. Guilmore, D.H., Hawthorn, R.J.S., Hart, D.M. Danazol for premenstrual syndrome: A preliminary report of a placebo-controlled double-blind study. J Int Med Res 1985, 13: 129.
47. Watts, J.F., Butt, W.R., Edwards, R.L. A clinical trial using Danazol for the treatment of premenstrual tension. Br J Obstet Gynaecol 1987, 94: 30.
48. Halbreich, U., Rojansky, N., Palter, S. Elimination of ovulation and menstrual cyclicity (with Danazol) improves dysphoric premenstrual syndromes. Fertil Steril 1991, 56: 1066.
49. Day, J.B. Danazol and the premenstrual syndrome. Postgrad Med J 1979, 55: 87.
50. Derzko, C.M. Role of Danazol in relieving the premenstrual syndrome. J Reprod Med 1990, 35(Suppl.): 97.
51. Muse, K.N., Cetel, N.S., Futterman, L.A., Yen, S.S.C. The premenstrual syndrome: Effects of "medical ovariectomy." New Engl J Med 1984, 311: 1345-9.
52. Hammarback, S., Backstrom. T. Induced anovulation as treatment of severe premenstrual tension syndrome. Acta Obstet Gynecol Scand 1988, 67: 159-66.
53. Mortola, J.F., Girton, L., Fischer, U. Successful treatment of severe premenstrual syndrome by combined use of gonadotropin-releasing hormone agonist and estrogen/progestin. J Clin Endocrinol Metab 1991, 72: 250-1.
54. Bancroft, J., Boyle, H., Warner, P., Fraser, H.M. The use of an LHRH agonist, buserelin, in the long-term management of premenstrual syndrome. Clin Endocrinol 1987, 26: 171-82.
55. Spicer, D.V., Pike, M.C., Pike, A., Rude, R., Shoupe, D., Richardson, J. Pilot trial of a gonadotropin hormone agonist with replacement hormones as a prototype contraceptive to prevent breast cancer. Contraception 1993, 47: 427-44.
56. Freeman, E.W., Sondheimer, S.J., Rickels, K., Albert, J. Gonadotropin-releasing hormone agonists in the treatment of premenstrual symptoms with and without comorbidity of depression: A pilot study. J Clin Psychiatry 1993, 54: 192-5.
57. West, C.P., Lumsden, M.A., Baird, D.T. Modification of symptoms of the premenstrual syndrome during ovarian suppression with goserelin (Zoladex) depot - Potential for research and clinical investigation. J Psychosom Obstet Gynecol 1989, 10: 79-8.
58. Johansen, J.S., Riis, B.J., Hassager, C. et al. The effect of a gonadotropin-releasing hormone agonist (nafarelin) on bone metabolism. J Clin Endocrinol Metab 1988, 67: 701-4.
59. Snajderman, M., Oliver, M.F. Spontaneous premature menopause, ischemic heart disease and serum lipids. Lancet 1963, 1: 962-4.
60. Mezrow, G., Shoupe, D., Spicer, D., Lobo, R., Leung, B., Pike, M. Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome. Fertil Steril 1994, 62: 932-7.
61. Friedman, A.J., Lobel, S.M., Rein, M.S., Barbieri, R.L. Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: The estrogen threshold hypothesis. Am J Obstet Gynecol 1990, 163: 1114.
62. Andersch, B., Hahn, L. Premenstrual complaints II: Influence of oral contraceptives. Acta Obstet Gynecol Scand 1981, 60: 579-83.
63. Graham, C.A., Sherwin, B.B. The relationship between retrospective premenstrual symptom reporting and present oral contraceptive use. J Psychosom Res 1987, 31: 45.
64. Morris, N.M., Udry, F.R. Contraceptive pills and the day to day feelings of well-being. Am J Obstet Gynecol 1972, 113: 763.
65. Silbergeld, S., Brast, N., Noble, E.P. The menstrual cycle: A double-blind study of symptoms, mood and behavior, and biochemical variables using Envoid and placebo. Psychosom Med 1971, 33: 411.
66. Yuk, V., Gumming, C., Fox, E., Cumming, D. Frequency and severity of premenstrual symptoms in women taking birth control pills. Gynecol Obstet Invest 1991, 31: 42.
67. Herzberg, B., Coppen, A. Changes in psychological symptoms in women taking oral contraceptives. Br J Psychiatry 1970, 116: 161.
68. Milsom, I., Sundell, G., Andersen, B. A longitudinal study of contraception and pregnancy outcome in a representative sample of young Swedish women. Contraception 1991, 43: 337-41.
69. Clare, A.W. Hormones, behaviour and the menstrual cycle. J Psychosom Res 1985, 29: 225-33.
70. Walker, A., Bancroft, J. Relationship between premenstrual symptoms and oral contraceptive use: A controlled study. Psychosom Med 1990, 52: 86.
71. Bancroft, J., Rennie, D. The impact of oral contraceptives on the experience of perimenstrual mood, clumsiness, food craving and other symptoms. J Psychosom Res 1993, 37: 195-202.
72. Backstrom, T., Hansson-Malmstrom, Y., Lindhe, B.A., Cavalli-Bjorkman, B., Nordenstrom, S. Oral contraceptives in premenstrual syndrome: A randomized comparison of triphasic and monophasic preparations. Contraception 1992, 46: 253-68.
73. Muse, K.N. Treatment of premenstrual syndrome with ovulation suppression. In: Modern Management of Premenstrual Syndrome. Smith, S., Schiff, I. (Eds.). W.W. Norton & Co.: New York 1993, 137-51.